Two Key Challenges for Effective Adenovirus-Mediated Liver Gene Therapy:Innate Immune Responses and Hepatocyte-Specific Transduction

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|9|2|115-127

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.9, Iss.2, 2009-04, pp. : 115-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Gene Therapy by Adenovirus-Mediated Gene Transfer

By  

Current Gene Therapy, Vol. 1, Iss. 1, 2001-05 ,pp. : 101-122

Bentham Science Publishers

Access to resources Recommend Favorite

Adenovirus-mediated gene therapy for ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Recent Advances in Adenovirus-mediated Gene Therapy for Cerebral Ischemia

By  

Current Gene Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 43-48

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Response to Helper Dependent Adenoviral Mediated Liver Gene Therapy: Challenges and Prospects

By  

Current Gene Therapy, Vol. 7, Iss. 5, 2007-10 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 109-118

Bentham Science Publishers

Access to resources Recommend Favorite